Key facts
- This page summarizes Elliott Robinson's Form 4 filing for Hinge Health, Inc. (HNGE).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 27 Aug 2026, 17:15.
Elliott Robinson - 25 Aug 2026 Form 4 Insider Report for Hinge Health, Inc. (HNGE)
- Reporting relationship
- Director
- Issuer ticker
- HNGE
- Reported as of
- 25 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Aug 2026, 17:15:48 UTC
- Prior SEC filing
- 21 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Augie Wilkinson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Elliott Robinson filed Form 4 for Hinge Health, Inc. (HNGE) on 27 Aug 2026.
Change
- Previous filing in this sequence was filed on 21 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002058536
Primary reporting owner
Robinson Elliott
- Relationship
- Director
- Address
- C/O BESSEMER VENTURE PARTNERS, 1865 PALMER AVENUE, SUITE 104, LARCHMONT
- Signature
- /s/ Augie Wilkinson, Attorney-in-Fact
- Signature date
- 27 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HNGE
transaction
Class A Common Stock
Sale
- Transaction value
- Shares
- 0
- Change %
- Price
- $0.000000*
- Shares after
- 0
- Date
- 25 Aug 2026
- Ownership
- See footnote
- Footnotes
- F1, F2
HNGE
transaction
Class A Common Stock
Sale
- Transaction value
- Shares
- 0
- Change %
- Price
- $0.000000*
- Shares after
- 0
- Date
- 26 Aug 2026
- Ownership
- See footnote
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On August 25, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 115,202 and 108,144 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.08. These shares were sold in multiple transactions at prices ranging from $90.50 to $91.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F2
The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
Footnote F3
On August 26, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 58,484 and 55,243 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.71. These shares were sold in multiple transactions at prices ranging from $91.20 to $92.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.